Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer

Journal of Urology

Volumn 163, Issue 4, 2000, Pages 1183-1188

  Okegawa, Takatsugu ^a   Nutahara, Kikuo ^a   Higashihara, Eiji ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biochemical recurrence; Polymerase chain reaction; Prostate; Prostate specific antigen; Prostate specific membrane antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

EID: 0034068005     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67718-X     Document Type: Article

References (26)

1. Catalona, W. J. and Smith, D. J.: 5-Year tumor recurrence rates after anatomical radical prostatectomy for prostate cancer. J Urol, part 2, 152: 1837, 1994
2. Epstein, J. I., Partin, A. W. and Sauvageot, J.: Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol, 20: 286, 1996
3. Stein, A., deKernion, J. B., Smith, R. B. et al: Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol, 147: 942, 1992
4. D'Amico, A. V., Whittington, R., Malkowicz, S. B. et al: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol, 154: 131, 1995
5. Pound, C. R., Partin, A. W., Eisenberger, M. A. et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
6. Israeli, R. S., Miller, W. H., Jr., Su, S. L. et al: Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane antigen derived primers in the polymerase chain reaction. J Urol, 153: 573, 1995
7. Cama. C., Olsson, C. A., Raffo, A. J. et al: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol, 153: 1373, 1995
8. Loric, S., Dumas, F., Eschwege, P. et al: Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcriptase polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem, 41: 1698, 1995
9. Zhang, Y., Zippe, C. D., Van Lente, F. et al: Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. Clin Cancer Res, 3: 1215, 1997
10. Grasso, Y. Z., Gupta, M. K., Levin, H. S. et al: Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res, 58: 1456, 1998
11. Okegawa, T., Yoshioka, J., Morita, R. et al: Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer. Int J Urol, 5: 349, 1998
12. Sokoloff, M. H., Tso, C.-L., Kaboo, R. et al: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol, 156: 1560, 1996
13. Ignatoff, J. M., Oefelein, M, G., Watkin, W. et al: Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. J Urol, 158: 1870, 1997
14. Okegawa, T., Nutahara, K. and Higashihara E.: Preoperative nested reverse transcription polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence following radical prostatectomy. Br J Urol, 84: 112, 1999
15. Urological tumours: prostate. In: TNM Classification of Malignant Tumours, 5th ed. International Union Against Cancer. New York: Wiley-Liss, p. 170, 1997
16. Danella, J. F., deKernion, J. B., Smith, R. B. et al: The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol, 149: 1488, 1993
17. Freeman, J. A., Esrig, D., Grossfeld, G. D. et al: Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer. J Urol, 154: 474, 1995
18. Stone, N. N., Stock, R. G. and Unger, P.: Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol, 154: 1392, 1995
19. Deguchi, T., Doi, T., Ehara, H. et al: Detection of micrometastatic prostate cancer cells in lymph nodes reverse transcriptase-polymerase chain reaction. Cancer Res, 53: 5350, 1993
20. Ferrari, A. C., Stone, N. N., Eyler, J. N. et al: Prospective analysis of prostate specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst, 89: 1498, 1997
21. Edelstein, R. A., Zietman, A. L., de las Morenas, A. et al: Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47: 370, 1996
22. Wood, D. P., Jr. and Banerjee, M.: Presence of circulating prostate cells in bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol, 15: 3451, 1997
23. Gao, C. L., Dean, R. C., Pinto, A. et al: Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. J Urol, 161: 1070, 1999
24. Olsson, C. A., de Vries, G. M., Raffo, A. J. et al: Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J Urol, 155: 1557, 1996
25. Ellis, W. J., Vessella, R. L., Corey, E. et al: The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer. J Urol, 159: 1134, 1998
26. Gao, C.-L., Maheshwari, S., Dean, R. C. et al: Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. Urology, 53: 714, 1999